MGP
DGX icon

Metis Global Partners’s Quest Diagnostics DGX Stock Holding History

Metis Global Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Sell
2,658
-491
-16% -$96.4K 0.01% 537
2026
Q1 		$617K Sell
3,149
-406
-11% -$78.9K 0.02% 544
2025
Q4 		$617K Sell
3,555
-2,649
-43% -$482K 0.01% 552
2025
Q3 		$1.18M Sell
6,204
-235
-4% -$41.7K 0.03% 435
2025
Q2 		$1.16M Sell
6,439
-644
-9% -$112K 0.03% 433
2025
Q1 		$1.2M Buy
7,083
+589
+9% +$96.8K 0.03% 425
2024
Q4 		$980K Sell
6,494
-716
-10% -$111K 0.03% 441
2024
Q3 		$1.12M Buy
7,210
+350
+5% +$52.3K 0.03% 418
2024
Q2 		$939K Buy
6,860
+143
+2% +$19.6K 0.03% 426
2024
Q1 		$894K Buy
6,717
+734
+12% +$95.2K 0.03% 439
2023
Q4 		$825K Sell
5,983
-1,099
-16% -$144K 0.03% 439
2023
Q3 		$863K Buy
7,082
+1,240
+21% +$165K 0.04% 415
2023
Q2 		$821K Buy
5,842
+424
+8% +$58.5K 0.04% 407
2023
Q1 		$767K Buy
5,418
+358
+7% +$51.2K 0.05% 387
2022
Q4 		$792K Buy
5,060
+3,045
+151% +$438K 0.07% 317
2022
Q3 		$247K Buy
2,015
+91
+5% +$12K 0.04% 463
2022
Q2 		$256K Sell
1,924
-18
-0.9% -$2.45K 0.04% 450
2022
Q1 		$266K Buy
+1,942
New +$271K 0.03% 461

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Metis Global Partners's DGX Position: Q2 2026 in Review

Metis Global Partners reduced its Quest Diagnostics (DGX) stake by 16% in Q2 2026, selling an estimated $96.4K and leaving 2,658 shares worth $563K. The position accounts for 0.01% of the portfolio, ranked #537.

Metis Global Partners first reported a position in DGX in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.2M in Q1 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Metis Global Partners held 2,658 shares of Quest Diagnostics worth $563K as of Q2 2026.
  • Metis Global Partners sold 491 Quest Diagnostics shares in Q2 2026, an estimated $96.4K.
  • Quest Diagnostics made up 0.01% of Metis Global Partners's portfolio in Q2 2026, its #537 holding.
  • Metis Global Partners first reported a position in Quest Diagnostics in Q1 2022 and has held it in 18 quarters since.
  • Metis Global Partners's Quest Diagnostics position peaked at $1.2M in Q1 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.